MED Historical PE Ratio Notes

— Medifast (ticker symbol: MED) is a health & wellness company specializing in weight management products & services, primarily through its signature OPTAVIA program. Instead of traditional retail channels, Medifast operates a direct-to-consumer model, leveraging a network of independent coaches to guide clients toward their health goals while selling meal replacements, shakes, & snacks. This business model provides strong recurring revenue but can also be subject to regulatory risks & shifts in consumer preferences. When you look at Medifast’s historical PE ratio, consider how earnings have been influenced by trends in consumer health, the competitive landscape amongst diet & nutrition companies, & the effectiveness of its coach-driven salesforce. Periods of rapid growth or margin expansion tend to lower the PE ratio if prices lag, while any concerns about sustainability or regulatory investigations can drive the multiple higher as earnings outlooks become cloudy. Thus, understanding MED’s core business model—and the volatility tied to its sales strategies and the broader wellness market—is essential as you interpret its historical price, earnings, and PE ratio data over time.

On this page we presented the MED Historical PE Ratio information for Medifast' stock. The average MED historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 18.7. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average MED historical PE based on this TTM earnings result method is 23.9. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this MED historical PE result, against the recent PE: when this page was posted on 8/10/2026, the most recent closing price for MED had been 12.09, and the most recent quarterly earnings result, annualized, was 0.88. Meanwhile, the most recent TTM earnings summed to 0.04. From these numbers, we calculate the recent MED PE on 8/10/2026 based on annualized quarterly EPS was 13.7. Based on MED's history, that recent PE is low relative to the historical average, with the recent PE 26.7% lower than the historical average PE across our data set for Medifast. Looking at the recent MED PE on 8/10/2026 based on TTM EPS, we calculate the ratio at 302.2. Based on MED's history, that recent PE is elevated relative to the historical average, with the recent PE 1164.4% higher than the historical average PE across our Medifast data set with TTM EPS used in the calculation at each period.

For self directed investors doing their due diligence on MED or any other given stock, valuation analysis for MED can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Medifast PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for MED. Thanks for visiting, and the next time you need to research MED Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.